MicroRNA‐132‐3p inhibits tumor malignant progression by regulating lysosomal‐associated protein transmembrane 4 beta in breast cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA‐132‐3p inhibits tumor malignant progression by regulating lysosomal‐associated protein transmembrane 4 beta in breast cancer
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume 110, Issue 10, Pages 3098-3109
Publisher
Wiley
Online
2019-08-07
DOI
10.1111/cas.14164
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Transcription Factor AP4 Promotes Oncogenic Phenotypes and Cisplatin Resistance by RegulatingLAPTM4BExpression
- (2018) Lu Wang et al. MOLECULAR CANCER RESEARCH
- AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity
- (2018) Yue Meng et al. Molecular Oncology
- A step-by-step microRNA guide to cancer development and metastasis
- (2017) Georgios S. Markopoulos et al. CELLULAR ONCOLOGY
- Transforming growth factor-β1 promotes breast cancer metastasis by downregulating miR-196a-3p expression
- (2017) Yan Chen et al. Oncotarget
- Aberrant Expression of Breast Development-Related MicroRNAs, miR-22, miR-132, and miR-212, in Breast Tumor Tissues
- (2016) Zahra Damavandi et al. Journal of Breast Cancer
- The role of microRNA-27a/b and microRNA-494 in estrogen-mediated downregulation of tissue factor pathway inhibitor α
- (2016) H. O. Ali et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Novel miRNA genes hypermethylated in breast cancer
- (2016) V. I. Loginov et al. MOLECULAR BIOLOGY
- MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4
- (2016) Weiwei Fu et al. PROSTATE
- MiR-501-5p regulates CYLD expression and promotes cell proliferation in human hepatocellular carcinoma
- (2015) De-Hao Huang et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Homeobox A9 directly targeted by miR-196b regulates aggressiveness through nuclear Factor-kappa B activity in non-small cell lung cancer cells
- (2015) Seong-Lan Yu et al. MOLECULAR CARCINOGENESIS
- miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression
- (2015) Hongtuan Zhang et al. Oncotarget
- Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum
- (2014) Marek Sochor et al. BMC CANCER
- Breast cancer in China
- (2014) Lei Fan et al. LANCET ONCOLOGY
- MiR-99a Antitumor Activity in Human Breast Cancer Cells through Targeting of mTOR Expression
- (2014) Yu Hu et al. PLoS One
- Integration of mRNA Expression Profile, Copy Number Alterations, and microRNA Expression Levels in Breast Cancer to Improve Grade Definition
- (2014) Claudia Cava et al. PLoS One
- Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors
- (2013) Andliena Tahiri et al. CARCINOGENESIS
- Overexpression of LAPTM4B: an independent prognostic marker in breast cancer
- (2013) Min Xiao et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Loss of microRNA-132 predicts poor prognosis in patients with primary osteosarcoma
- (2013) Jie Yang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation
- (2013) Shuai Li et al. PATHOLOGY RESEARCH AND PRACTICE
- cAMP Responsive Element Binding Protein-1 Is a Transcription Factor of Lysosomal-Associated Protein Transmembrane-4 beta in Human Breast Cancer Cells
- (2013) Meng Zhang et al. PLoS One
- Overexpression of LAPTM4B-35 is associated with poor prognosis in colorectal carcinoma
- (2012) Yue Kang et al. AMERICAN JOURNAL OF SURGERY
- Association of LAPTM4B gene polymorphism with breast cancer susceptibility
- (2012) Meirong Fan et al. Cancer Epidemiology
- MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function
- (2012) B. H. Miller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Overexpression of LAPTM4B-35 attenuates epirubucin-induced apoptosis of gallbladder carcinoma GBC-SD cells
- (2011) Li Zhou et al. SURGERY
- LAPTM4B-35 Overexpression Is an Independent Prognostic Marker in Endometrial Carcinoma
- (2010) Fan-ling Meng et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer
- (2010) Yang Li et al. NATURE MEDICINE
- MicroRNA-132–mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis
- (2010) Sudarshan Anand et al. NATURE MEDICINE
- LAPTM4B: A novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling
- (2010) L Li et al. ONCOGENE
- LAPTM4B-35, a novel tetratransmembrane protein and its PPRP motif play critical roles in proliferation and metastatic potential of hepatocellular carcinoma cells
- (2009) Xinrong Liu et al. CANCER SCIENCE
- Boosting the Brain's Ability to Block Inflammation via MicroRNA-132
- (2009) Luke A.J. O'Neill IMMUNITY
- LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma
- (2009) Hua Yang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started